New Legislator Spotlight: Congressman Harley Rouda (D-Laguna Beach)
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Congressman Harley Rouda (D-Laguna Beach). We look forward to working with Rep. Rouda and his team to advance policies that improve patient health and bring positive change for California patients and their families.
New Legislator Spotlight: State Senator Ling Ling Chang (R-Diamond Bar)
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes State Senator Ling Ling Chang (R-Diamond Bar). We look forward to working with Senator Chang and her team to advance policies that improve patient health and bring positive change for California patients and their families.
CLSA in BioSpace: California Life Sciences Association Names Three Life Science Champions
CLSA was recently featured in BioSpace regarding the Association’s 2018 Life Sciences Champions awards that took place in Sacramento.
CLSA Opposes Trump Administration’s Proposal to Restrict Patient Access to Medicines in “Six Protected Classes” in Medicare Part D
In November 2018, the Trump Administration proposed a rule that would weaken patient protections within Medicare’s Part D prescription drug benefit. Currently, Medicare Part D drug plans are required to comply with the “protected drug classes” policy, which ensure that beneficiaries have access to “all or substantially all” drugs in six specific classes of medicines (like antiretrovirals, antidepressants, antipsychotics, and anticonvulsant agents).
Animal Research Mandatory Reporting Bill Introduced in California State Legislature
By Brett Johnson March 20, 2019 Assembly Bill (AB) 889, introduced by Assemblymember Brian Maienschein, would require detailed reporting on animals used in research in California. The total number of animals kept during the previous year and the purposes for which each animal was used would be required to be reported, and the State Department of Public … Continue reading Animal Research Mandatory Reporting Bill Introduced in California State Legislature
New Legislator Spotlight: Assemblyman James Ramos (D-Highland)
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Assemblyman James Ramos (D-Highland). We look forward to working with Assemblyman Ramos and his team to advance policies that improve patient health and bring positive change for California patients and their families.
Congress to Introduce CLSA-Endorsed Legislation to Repeal Medical Device Tax & Protect Medical Innovation
In the coming weeks, legislation will be introduced to permanently repeal the medical device excise tax.
Assemblymember Jim Wood Introduces Bill Targeting Agreements between Brand and Generic Drug Companies
On Wednesday, Feb. 20, California Attorney General Xavier Becerra and Chair of Assembly Health, Assemblymember Jim Wood, held a press conference to announce the introduction of legislation, Assembly Bill (AB) 824 (Wood), aimed at enabling the California Department of Justice (DOJ) to go after so-called “pay-for-delay” agreements.
CLSA Board Members Visit the State Capitol and Meet with Governor’s Staff
On Tuesday, Feb. 26, members and representatives of the CLSA Board visited the State Capitol to meet with Governor’s Office staff and legislators from both Senate and Assembly chambers.
CLSA Appoints Andrew Setikas as Senior Vice President of Business Development and Strategy
CLSA today announced the appointment of Andrew Setikas as Senior Vice President of Business Development and Strategy starting March 25, 2019. The addition of Setikas to CLSA’s senior leadership team marks the continued expansion and rapid growth of CLSA, which advances California’s world-leading life sciences sector by advocating for effective national, state and local public policies and supporting entrepreneurs and life sciences businesses.